PGT-A is a genetic screening of embryos for the correct number of chromosomes before transfer. Because chromosomal abnormalities are a leading cause of implantation failure and early miscarriage, PGT-A helps identify embryos most likely to result in a healthy pregnancy. A small number of cells are taken from each blastocyst for analysis; only chromosomally normal embryos are selected for transfer.
IVF
PGT-A — Preimplantation Genetic Testing for Aneuploidy
Explore More
Related Services
Ovarian PRP
Ovarian PRP and Exosome therapy are innovative treatments for women with diminished ovarian reserve, aiming to improve egg quality and quantity before IVF.
Learn MoreHow Successful Is the Drug-Free IVM Method?
IVM (In Vitro Maturation) is a fertility treatment alternative where immature eggs are collected with minimal or no hormone stimulation, then matured in a laboratory.
Learn MoreFrozen Embryo Transfer (FET)
Frozen Embryo Transfer allows previously cryopreserved embryos to be transferred in a subsequent cycle, offering a gentler, cost-effective route to pregnancy.
Learn MoreFrequently Asked Questions
Common Questions
Patients of more advanced maternal age, those with recurrent miscarriage, multiple failed transfers, or couples wanting to reduce miscarriage risk.
No, when performed by an experienced embryologist on day-5/6 blastocysts.
No test does. PGT-A reduces certain risks but does not detect every genetic condition.
Only blastocysts that are eligible for biopsy.
Usually within a few weeks; transfer is then planned in a frozen cycle.
Book Your Appointment Today
We provide a comfortable environment where you can consult us with all your problems in the field of Obstetrics, Gynecology and IVF Treatment.